{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:54:17Z","timestamp":1791986057995,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cmi.2014.12.027","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T19:33:41Z","timestamp":1421264021000},"page":"491.e1-491.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Puig-Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ruiz-Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Delgado-Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bereciartua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2014.12.027_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib2","doi-asserted-by":"crossref","first-page":"O50","DOI":"10.1111\/1469-0691.12312","article-title":"A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies","volume":"20","author":"Gamaletsou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2014.12.027_bib3","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): Stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2014.12.027_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: Risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2014.12.027_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in europe: Results of 28-month european confederation of medical mycology (ecmm) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib6","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and candida krusei as the leading causes of candidemia in hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2014.12.027_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: A prospective, multicenter surveillance study by the invasive fungal infection group (ifig) of the european organization for research and treatment of cancer (eortc)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/myc.12013","article-title":"Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in brazil","volume":"56","author":"Bergamasco","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2014.12.027_bib9","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in candida bloodstream infections: A population-based surveillance in spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Cl Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2014.12.027_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Rodriguez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2014.12.027_bib11","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2014.12.027_bib12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2014.12.027_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib14","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1128\/JCM.00605-14","article-title":"Diagnostic usefulness of differential time to positivity for catheter-related candidemia","volume":"52","author":"Park","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.cmi.2014.12.027_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2014.12.027_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum beta-lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","article-title":"A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients","volume":"45","author":"McGregor","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.02155-13","article-title":"Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011","volume":"58","author":"Guinea","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2014.12.027_bib19","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.01031-09","article-title":"Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species","volume":"53","author":"Mann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2014.12.027_bib20","unstructured":"Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: A prospective multicenter study involving 2,441 patients. Antimicrob Agents Chem"},{"key":"10.1016\/j.cmi.2014.12.027_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/323812","article-title":"Risk factors for Candida tropicalis fungemia in patients with cancer","volume":"33","author":"Kontoyiannis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib22","doi-asserted-by":"crossref","first-page":"e59373","DOI":"10.1371\/journal.pone.0059373","article-title":"Epidemiology of candidemia in Latin America: A laboratory-based survey","volume":"8","author":"Nucci","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cmi.2014.12.027_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003","volume":"44","author":"Almirante","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2014.12.027_bib24","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1128\/AAC.00741-06","article-title":"In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole","volume":"50","author":"Clancy","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2014.12.027_bib25","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection","volume":"56","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2014.12.027_bib26","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2014.12.027_bib27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: Results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata; risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.cmi.2014.12.027_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2014.12.027_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/clinids\/23.3.506","article-title":"Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains","volume":"23","author":"Girmenia","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0732-8893(02)00423-6","article-title":"Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades","volume":"44","author":"Safdar","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2014.12.027_bib34","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1128\/AAC.00690-11","article-title":"Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case\u2013control study in Paris, France","volume":"55","author":"Blanchard","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15001810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15001810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:39:58Z","timestamp":1768952398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15001810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1198743X15001810"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2014.12.027","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2014.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}